Hydralazine Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg, 25 mg, 50 mg, 100 mg
Reference Brands: Apresoline(US & Eu)
Category:
Hypertension
Hydralazine is a direct vasodilator that relaxes arteriolar smooth muscle, reducing blood pressure and afterload. It effectively treats hypertension and heart failure. Benefits include rapid blood pressure lowering, symptom relief, improved cardiac output, decreased stroke risk, and better long-term cardiovascular health, especially in hypertensive emergencies.
Hydralazine tablets is available in Tablets
and strengths such as 10 mg, 25 mg, 50 mg, 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Hydralazine tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Hydralazine tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Hydralazine tablets, marketed as Apresoline, are approved in the US by the FDA and in the EU via EMA for managing severe hypertension and heart failure. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Adequate regional adherence supports timely approval, safe medication use, and worldwide availability, helping healthcare providers manage cardiovascular risks effectively across regions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing